Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 34 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
NCT05272384
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Yale University New Haven, Connecticut, United States
NCT06487624
- Conditions
- Advanced Solid Tumor, Bone Diseases, Bone Diseases, Developmental, +15 more
- Locations
-
- Prisma Health-Upstate Greenville, South Carolina, United States
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China
- Zhejiang Provincial Cancer Hospital Hangzhou, China
- Xuzhou Central Hospital Xuzhou, China
NCT06484920
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
NCT04871607
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT05595447
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- Hospital Regional Alta Especialidad Bajio León, Guanajuato, Mexico
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
NCT07021989
- Conditions
- Classic Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
- Locations
-
- University of California Davis Davis, California, United States
- University of California San Francisco-Fresno Fresno, California, United States
- University of California Irvine Irvine, California, United States
- University of California, San Diego La Jolla, California, United States
NCT03259503
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04640779
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +24 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT01231412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
- Locations
-
- University of Colorado Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- Conditions
- Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, +91 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
NCT04681105
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT02227199
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03739619
- Conditions
- Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
NCT02744612
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- NYP/Weill Cornell Medical Center New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT01701986
- Conditions
- Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02824029
- Conditions
- Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
- Locations
-
- University of Michigan Health System Ann Arbor, Michigan, United States
- Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
- University of Tennessee Knoxville, Tennessee, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT04052997
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UCSF Health - Hematology and Blood and Marrow Transplant Clinic San Francisco, California, United States
- Stanford University Medical Center Stanford, California, United States
NCT03013933
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant
NCT02869633
- Conditions
- Blastoid Variant Mantle Cell Lymphoma, Chronic Disease, Disease Attributes, +27 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Stanford Cancer Institute Palo Alto, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT02304458
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +53 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States